232 related articles for article (PubMed ID: 26972930)
1. Diabetes mellitus in patients with cirrhosis: clinical implications and management.
Elkrief L; Rautou PE; Sarin S; Valla D; Paradis V; Moreau R
Liver Int; 2016 Jul; 36(7):936-48. PubMed ID: 26972930
[TBL] [Abstract][Full Text] [Related]
2. Hepatogenous diabetes. Current views of an ancient problem.
García-Compean D; Jaquez-Quintana JO; Maldonado-Garza H
Ann Hepatol; 2009; 8(1):13-20. PubMed ID: 19221528
[TBL] [Abstract][Full Text] [Related]
3. [Hepatogenous diabetes - diagnostics and treatment].
Gundling F; Schumm-Draeger PM; Schepp W
Z Gastroenterol; 2009 May; 47(5):436-45. PubMed ID: 19418413
[TBL] [Abstract][Full Text] [Related]
4. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome.
Kasmari AJ; Welch A; Liu G; Leslie D; McGarrity T; Riley T
Am J Med; 2017 Jun; 130(6):746.e1-746.e7. PubMed ID: 28109969
[TBL] [Abstract][Full Text] [Related]
5. Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis.
Kumar R
Indian J Endocrinol Metab; 2018; 22(4):552-559. PubMed ID: 30148106
[TBL] [Abstract][Full Text] [Related]
6. [Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications].
Buyse S; Valla D
Gastroenterol Clin Biol; 2007 Mar; 31(3):266-73. PubMed ID: 17396083
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of metformin in patients with type 2 diabetes mellitus and chronic hepatitis C.
Harris K; Smith L
Ann Pharmacother; 2013 Oct; 47(10):1348-52. PubMed ID: 24259699
[TBL] [Abstract][Full Text] [Related]
8. Managing diabetes and liver disease association.
Hamed AE; Elsahar M; Elwan NM; El-Nakeep S; Naguib M; Soliman HH; Ahmed Aboubakr A; AbdelMaqsod A; Sedrak H; Assaad SN; Elwakil R; Esmat G; Salh S; Mostafa T; Mogawer S; Sadek SE; Saber MM; Ezelarab H; Mahmoud AA; Sultan S; El Kassas M; Kamal E; ElSayed NM; Moussa S
Arab J Gastroenterol; 2018 Dec; 19(4):166-179. PubMed ID: 30420265
[TBL] [Abstract][Full Text] [Related]
9. Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients.
Nkontchou G; Cosson E; Aout M; Mahmoudi A; Bourcier V; Charif I; Ganne-Carrie N; Grando-Lemaire V; Vicaut E; Trinchet JC; Beaugrand M
J Clin Endocrinol Metab; 2011 Aug; 96(8):2601-8. PubMed ID: 21752887
[TBL] [Abstract][Full Text] [Related]
10. Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.
Casadei Gardini A; Faloppi L; De Matteis S; Foschi FG; Silvestris N; Tovoli F; Palmieri V; Marisi G; Brunetti O; Vespasiani-Gentilucci U; Perrone G; Valgiusti M; Granato AM; Ercolani G; Negrini G; Tamburini E; Aprile G; Passardi A; Santini D; Cascinu S; Frassineti GL; Scartozzi M
Eur J Cancer; 2017 Nov; 86():106-114. PubMed ID: 28985579
[TBL] [Abstract][Full Text] [Related]
11. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.
Garcia-Compean D; Jaquez-Quintana JO; Gonzalez-Gonzalez JA; Maldonado-Garza H
World J Gastroenterol; 2009 Jan; 15(3):280-8. PubMed ID: 19140227
[TBL] [Abstract][Full Text] [Related]
12. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
Orsi E; Grancini V; Menini S; Aghemo A; Pugliese G
Liver Int; 2017 Jul; 37(7):950-962. PubMed ID: 27943508
[TBL] [Abstract][Full Text] [Related]
13. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
14. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
15. Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments.
Clarembeau F; Bale G; Lanthier N
Clin Sci (Lond); 2020 Aug; 134(16):2117-2135. PubMed ID: 32820802
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus].
Kim MG; Choi WC
Korean J Hepatol; 2006 Dec; 12(4):524-9. PubMed ID: 17237630
[TBL] [Abstract][Full Text] [Related]
17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
18. [Metabolic disturbances in liver cirrhosis (part 2), hepatogenous diabetes: diagnostic aspects and treatment].
Gundling F; Seidl H; Löffler N; Strassen I; Schepp W
Dtsch Med Wochenschr; 2010 Jan; 135(1-2):22-4. PubMed ID: 20024879
[TBL] [Abstract][Full Text] [Related]
19. [Hepatogenic diabetes].
Perseghin G; Caloni M; Mazzaferro V; Luzi L
Recenti Prog Med; 2001 Dec; 92(12):757-61. PubMed ID: 11822099
[TBL] [Abstract][Full Text] [Related]
20. Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis.
Kaplan DE; Serper M; John BV; Tessiatore KM; Lerer R; Mehta R; Fox R; Aytaman A; Baytarian M; Hunt K; Albrecht J; Taddei TH;
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2148-2160.e14. PubMed ID: 32798709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
